FORT COLLINS, Colo., Sept. 12, 2024 /PRNewswire/ -- GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer research, and pathogen detection ...

CDC assay service Complement-dependent cytotoxicity assay service. Complement-dependent cytotoxicity (CDC) in mAb-based therapy starts with binding the complement protein C1q to the Fc domain of ...

The ASRs are being developed on the Panther Fusion ® system, a fully automated molecular testing platform that allows labs to quickly consolidate and run multiple assays for women's health ...

GT Molecular, Inc., a company providing ultrasensitive PCR assays for wastewater-based epidemiology, cancer research, and pathogen detection, was awarded the Center for Disease Control's (CDC ...